TOMM40 and Parkinson disease: Building upon recent findings that suggest that PARP inhibition promotes the degradation of α-Syn aggregates via the autophagy-lysosomal pathway in PD models [33], here, we explored the potential of PARP inhibition in countering α-Syn-mediated TOM40 protein loss resulting from exposure to 6OHDA and elevated α-Syn expression.